期刊论文详细信息
Cancer Nanotechnology
Dual role of nanoparticles as drug carrier and drug
Original Paper
Anjan Kr. Dasgupta1  Hirak Kumar Patra1  Sounik Sarkar2  Indranil Biswas3  Arnab Chattopadhyay3 
[1] Department of Biochemistry, University of Calcutta, 35 Ballygunge Circular Road, 700019, Kolkata, India;Department of Biochemistry, University of Calcutta, 35 Ballygunge Circular Road, 700019, Kolkata, India;Institute of Haematology and Transfusion Medicine, MCH Building (2nd floor), Medical College 88 College Street, 700073, Kolkata, India;Institute of Haematology and Transfusion Medicine, MCH Building (2nd floor), Medical College 88 College Street, 700073, Kolkata, India;
关键词: Gold nanoparticle;    Vincristine sulfate;    Multiple myeloma;    Cell cycle;    Drug delivery;   
DOI  :  10.1007/s12645-010-0011-3
 received in 2010-11-02, accepted in 2010-12-07,  发布年份 2011
来源: Springer
PDF
【 摘 要 】

The conventional chemotherapeutic agents used in the treatment of human malignancies are directed nonspecifically against both malignant and nonmalignant cells, often limiting their efficacy with having serious side effects. Recent development of drug delivery vehicles has opened up the possibility of targeted drug delivery systems with the potential of achieving maximum efficacy with minimal toxicity. The possibility of using a nanomaterial as a combinational drug component is intuitively evident as it would compensate the toxicity level by enhancing drug delivery efficiency. Additionally, cell-specific cytotoxicity (reported earlier by our group) of the nanovehicle itself may potentiate a more effective targeted cell killing. In this paper, we explore the possibility of using gold nanoparticles playing the dual role of an anticancer agent and a carrier of a chemotherapeutic drug. This is demonstrated using vincristine sulfate (VS), salt of an alkaloid often used in the treatment of multiple myeloma (MM), and U266 as a test MM cell line. The drug VS shows the expected G2-M-phase arrest of cells. Notably, bare gold nanoparticle shows arrest of the S phase cells that may be particularly important in case of slow-growing malignancies like MM where most of the cells remain in G1 phase of the cell cycle. The VS conjugated gold retains the activity of both gold nanoparticle and VS leading to a synergistic rise of the apoptotic cell population.

【 授权许可】

Unknown   
© Springer-Verlag 2010

【 预 览 】
附件列表
Files Size Format View
RO202311090166355ZK.pdf 5924KB PDF download
【 参考文献 】
  • [1]
  • [2]
  • [3]
  • [4]
  • [5]
  • [6]
  • [7]
  • [8]
  • [9]
  • [10]
  • [11]
  • [12]
  • [13]
  • [14]
  • [15]
  • [16]
  • [17]
  • [18]
  • [19]
  • [20]
  • [21]
  • [22]
  • [23]
  • [24]
  • [25]
  • [26]
  • [27]
  • [28]
  • [29]
  • [30]
  • [31]
  文献评价指标  
  下载次数:8次 浏览次数:0次